KFP
SRPT icon

KB Financial Partners’s Sarepta Therapeutics SRPT Stock Holding History

KB Financial Partners’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$31K Hold
253
– – 0.01% 310
2023
Q2 		$29K Sell
253
-5
-2% -$645 0.01% 331
2023
Q1 		$36K Hold
258
– – 0.01% 296
2022
Q4 		$33K Sell
258
-51
-17% -$5.91K 0.01% 304
2022
Q3 		$34K Hold
309
– – 0.01% 282
2022
Q2 		$23K Buy
+309
New +$22.7K 0.01% 322

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

KB Financial Partners's SRPT Position: Q3 2023 in Review

KB Financial Partners held its Sarepta Therapeutics (SRPT) position steady in Q3 2023 at 253 shares worth $31K. The position accounts for 0.01% of the portfolio, ranked #310.

KB Financial Partners first reported a position in SRPT in Q2 2022 and has held it in 6 quarters since. The position peaked at $36K in Q1 2023. 394 funds tracked by Wall St. Rank hold SRPT as of Q3 2023.

  • KB Financial Partners held 253 shares of Sarepta Therapeutics worth $31K as of Q3 2023.
  • KB Financial Partners left its Sarepta Therapeutics share count unchanged in Q3 2023.
  • Sarepta Therapeutics made up 0.01% of KB Financial Partners's portfolio in Q3 2023, its #310 holding.
  • KB Financial Partners first reported a position in Sarepta Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • KB Financial Partners's Sarepta Therapeutics position peaked at $36K in Q1 2023.
  • 394 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.